Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans
Open Access
- 1 April 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 27 (4) , 625-631
- https://doi.org/10.1128/aac.27.4.625
Abstract
Mice receiving a single intraperitoneal injection of amphotericin B showed increased resistance to subsequent challenge with either Candida albicans or Staphylococcus aureus. This enhancement of resistance was obvious in terms of both survival criteria and clearance of the intravenously injected organism from different organs. The protective effect of amphotericin B was conditioned by dose, time of drug administration, and size of yeast or bacterial inoculum and was reversed by cyclophosphamide. Effector cells from mice treated with amphotericin B displayed enhanced fungicidal activity in vitro as measured in a short-term 51Cr release assay. Macrophages from intact animals exposed in vitro to amphotericin B also acquired strong candidacidal reactivity.This publication has 19 references indexed in Scilit:
- A radiolabel release microassay for phagocytic killing of Candida albicansJournal of Immunological Methods, 1982
- Excretion Pathways of Amphotericin BThe Journal of Infectious Diseases, 1979
- Modulation of macrophage tumoricidal capability by polyene antibiotics: support for membrane lipid as a regulatory determinant of macrophage function.Proceedings of the National Academy of Sciences, 1978
- Amphotericin B Pharmacokinetics in HumansAntimicrobial Agents and Chemotherapy, 1978
- Augmentation of murine immune responses by amphotericin BCellular Immunology, 1977
- Spectrum of in vivo and in vitro cell-mediated immune responses in coccidioidomycosisCellular Immunology, 1977
- Effects of Amphotericin B on Macrophages and Their Precursor CellsAntimicrobial Agents and Chemotherapy, 1977
- Changes in Murine Resistance to Listeria monocytogenes Infection Induced by Amphotericin BThe Journal of Infectious Diseases, 1973
- Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.1971
- IMMUNOLOGICAL OBSERVATIONS IN CHRONIC MUCOCUTANEOUS CANDIDIASISThe Lancet, 1969